INDAPTUS THERAPEUTICS INC

Indaptus Therapeutics shares jumped 6.8% to $3.18 on Oct 23, 2026, after a private placement and 13D updates – see market cap, volume, and key indicators.

Indaptus Therapeutics’ stock climbs 6.8% as a $1.7 M private placement fuels growth, boosting its market cap to $394 M and highlighting its bacteria‑based immuno‑therapy platform.

Indaptus Therapeutics (INDP) climbs 3.8% to $2.96, above its 200‑day SMA, as microbiome‑based biotech buzz and partnership prospects lift investor interest.